staurosporine has been researched along with Benign Mastocytoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gleixner, KV; Hadzijusufovic, E; Mirkina, I; Peter, B; Pickl, WF; Schuch, K; Thaiwong, T; Valent, P; Willmann, M; Yuzbasiyan-Gurkan, V | 1 |
| Kitani, S; Morita, Y; Nakamura, R; Sasaki, N; Sato, Y; Sawada, J; Teshima, R | 1 |
2 other study(ies) available for staurosporine and Benign Mastocytoma
| Article | Year |
|---|---|
H1-receptor antagonists terfenadine and loratadine inhibit spontaneous growth of neoplastic mast cells.
Topics: Animals; Apoptosis; Blotting, Western; Caspase 3; Cats; Cell Line, Tumor; Cell Proliferation; Dasatinib; Dogs; Dose-Response Relationship, Drug; Drug Synergism; Flow Cytometry; Histamine H1 Antagonists, Non-Sedating; Humans; Inhibitory Concentration 50; Loratadine; Mastocytoma; Mastocytosis, Systemic; Proto-Oncogene Proteins c-kit; Pyrimidines; Staurosporine; Terfenadine; Thiazoles; Tumor Cells, Cultured | 2010 |
IgG-mediated signal transduction in canine mastocytoma-derived cells.
Topics: Acridines; Animals; Binding Sites; Calcium; Calcium Signaling; Dogs; Histamine Release; Immunoglobulin E; Immunoglobulin G; Mastocytoma; Neoplasm Proteins; Phosphorylation; Signal Transduction; Staurosporine; Thapsigargin; Tumor Cells, Cultured; Tyrosine | 2002 |